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 X-ray crystal structure of glycinamide ribonucleotide synthetase from
Escherichia coli. Weiru Wang, T Joseph Kappock, JoAnne Stubbe and Steven E
Ealick (1998). Biochemistry 37, 15647–15662.
Glycinamide ribonucleotide synthetase (GAR-syn) catalyzes
the second step of the de novo purine biosynthetic pathway;
the conversion of phosphoribosylamine, glycine, and ATP to
glycinamide ribonucleotide (GAR), ADP, and Pi. GAR-syn
adopts an α/β structure that consists of four domains labeled N,
A, B, and C. The N, A, and C domains are clustered to form a
large central core structure whereas the smaller B domain is
extended outward. GAR-syn is similar to D-alanine:D-alanine
ligase, biotin carboxylase, and glutathione synthetase, despite
low sequence similarity.
10 November 1998, Biochemistry
 Structure of human adenosine kinase at 1.5 Å resolution. Irimpan I
Mathews, Mark D Erion and Steven E Ealick (1998). Biochemistry 37,
15607–15620.
Adenosine kinase (AK) is a key enzyme in the regulation of
extracellular adenosine and intracellular adenylate levels. The
crystal structure consists of one large α/β domain with nine β-
strands, eight α-helices, and one small α/β-domain with five β-
strands and two α-helices. The active site is formed along the
edge of the β-sheet in the large domain while the small domain
acts as a lid to cover the upper face of the active site. The
overall structure is similar to ribokinase from Escherichia coli
and represents the second structure of a new family of
carbohydrate kinases.
10 November 1998, Biochemistry
 Crystal structure of thiaminase-I from Bacillus thiaminolyticus at 2.0 Å
resolution. Nino Campobasso, Colleen A Costello, Cynthia Kinsland, Tadhg P
Begley, and Steven E Ealick (1998). Biochemistry 37,15981–15989.
Thiaminase-I catalyzes the replacement of the thiazole moiety
of thiamin with a wide variety of nucleophiles, such as
pyridine, aniline, catechols, quinoline, and cysteine. The
crystal structure of the enzyme from Bacillus thiaminolyticus
contains two α/β-type domains separated by a large cleft. At
the base of the cleft lies Cys113, previously identified as a key
active site nucleophile. The structure with a covalently bound
thiamin analogue, which functions as a mechanism-based
inactivating agent, confirms the location of the active site.
10 November 1998, Biochemistry
 Crystal structure and functional analysis of the HERG potassium channel
N terminus: A eukaryotic PAS domain. Joao H Morais Cabral, Alice Lee,
Steven L Cohen, Brian T Chait, Min Li and Roderick Mackinnon (1998). Cell 95,
649–655.
The HERG voltage-dependent K+ channel plays a role in
cardiac electrical excitability, and, when defective, it underlies
one form of the long QT syndrome. The authors have
determined the crystal structure of the HERG K+ channel 
N-terminal domain and studied its role as a modifier of gating
using electrophysiological methods. The domain is similar in
structure to a bacterial light sensor photoactive yellow protein
and provides the first three-dimensional model of a eukaryotic
PAS domain. Scanning mutagenesis of the domain surface has
allowed the identification of a hydrophobic ‘hotspot’ forming a
putative interface with the body of the K+ channel to which it
tightly binds.
25 November 1998, Cell
 Crystal structure and ATPase activity of MutL: implications for DNA
repair and mutagenesis. Changill Ban and Wei Yang (1998). Cell 95, 541–552.
Mutl and its homologs are essential for DNA mismatch
repair. Mutations in genes encoding human homologs of
MutL cause multiorgan cancer susceptibility. The authors
have determined the crystal structure of a 40 kDa N-terminal
fragment of E. coli MutL that retains all of the conserved
residues in the MutL family. The structure of MutL is
homologous to that of an ATPase-containing fragment of
DNA gyrase. The structure provides evidence that the
flexible, yet conserved, loops surrounding the ATP-binding
site undergo conformational changes upon ATP hydrolysis,
thereby modulating interactions between MutL and other
components of the repair machinery.
13 November 1998, Cell
 Atomic structure of clathrin: a β propeller terminal domain joins an α
zigzag linker. Ernst ter Haar, Andrea Musacchio, Stephen C Harrison and Tomas
Kirchhausen(1998). Cell 95, 563–573.
Clathrin triskelions form the lattice that organizes
recruitment of proteins to coated pits and helps drive
vesiculation of the lipid bilayer. The authors report the
crystal structure at 2.6 Å resolution of a 55 KDa N-terminal
fragment from the 190 kDa  clathrin heavy chain. The
structure comprises the globular “terminal domain” and the
linker that joins it to the end of a triskelion leg. The termnal
domain is a seven-blade β propeller, a structure well adpated
to interaction with multiple partners, such as the Ap-1 and
Ap-2 sorting adaptor complexes and the nonvisual arrestins.
The linker is an α−helical zigzag emanating from the
propeller domain. The authors propose that this simple motif
may extend into the rest of the clathrin leg.
13 November 1998, Cell
 Structure of an XRCC1 BRCT domain: a new protein-protein interaction
module. Xiaodong Zhang, Solange Moréra, Paul A Bates, Philip C Whitehead,
Arnold I Coffer, Karl Hainbucher, Rachel A Nash, Michael JE Sternberg, Tomas
Lindahl and Paul S Freemont (1998). EMBO J. 17, 6404–6411.
The BRCT domain (BRCA1 C-terminus), is a conserved
protein–protein interaction region of ~95 amino acids found
in proteins involved in DNA repair, recombination and cell
cycle control. The crystal structure from the C-terminal
region of the human DNA repair protein XRCC1, comprises
a four-stranded parallel β-sheet surrounded by three α-
helices. The domain forms a homodimer in the crystals,
suggesting how it forms a stable heterodimer with the BRCT
domain of DNA ligase III.
2 November 1998, The EMBO Journal
 Structure of the IGF-binding domain of the insulin-like growth factor-
binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor
interactions. Wenzel Kalus, Markus Zweckstetter, Christian Renner, Yolanda
Sanchez, Julia Georgescu, Michael Grol, Dirk Demuth, Ralf Schumacher, Carola
Dony, Kurt Lang and Tad A Holak (1998). EMBO J. 17, 6558–6572.
Binding proteins for insulin-like growth factors (IGFs) IGF-I
and IGF-II, known as IGFBPs, control the distribution,
function and activity of IGFs in various cell tissues and body
fluids. The solution structure of an N–terminal fragment
(residues 40–92) of IGFBP-5 consists of a central three-
stranded anti-parallel β-sheet stabilized by two disulfide
bridges. The binding to IGFs, which is in the nanomolar range,
involves conserved Leu and Val residues localized in a
hydrophobic surface patch.
17 November 1998, The EMBO Journal
 An evolutionary link between sporulation and prophage induction in the
structure of a repressor: anti-repressor complex. Richard J Lewis, James A
Brannigan, Wendy A Offen, Issar Smith and Anthony J Wilkinson (1998). J. Mol.
Biol. 283, 907–912.
In Bacillus subtilis the proteins of the sin, sporulation inhibition,
region form a component of an elaborate molecular circuitry
that regulates the commitment to sporulation. SinR is a
tetrameric repressor protein. Repression is overcome by SinI,
which disrupts the SinR tetramer through the formation of a
SinI–SinR heterodimer. The interactions governing this
quaternary transition are revealed in the crystal structure of the
SinI–SinR complex. The DNA-binding domain of SinR is
identical with that of the corresponding domains of the
repressor proteins, CI and Cro, of bacteriophage 434 that
regulate lysis/lysogeny.
13 November 1998, Journal of Molecular Biology
 NMR solution structure of the lead-dependent ribozyme: evidence for
dynamics in RNA catalysis. Charles G Hoogstraten, Pascale Legault and Arthur
Pardi (1998). J. Mol. Biol. 284, 337–350.
The NMR solution structure of a lead-dependent ribozyme,
known as the leadzyme, is presented. This ribozyme is
among the smallest of the known catalytic RNAs, with an
active site consisting of a six-nucleotide asymmetric internal
loop. This loop has a roughly double-helical structure,
including a protonated adenine-cytosine wobble base-pair,
that positions the cytosine base 5' to the cleavage site in a
double-helical conformation. The deviations from helical
structure consist of two bulged guanosine residues, G7 and
G9, where G7 is the residue 3' to the cleavage site. The
scissile phosphate group of the leadzyme is not positioned for
in-line nucleophilic attack. Therefore, a conformational
rearrangement in the active site is required to reach the
proposed transition state for this ribozyme. 
27 November 1998, Journal of Molecular Biology
 Global analysis of the effects of temperature and denaturant on the
folding and unfolding kinetics of the N-terminal domain of the protein L9.
Brian Kuhlman, Donna L Luisi, Philip A Evans  and Daniel P Raleigh (1998). J. Mol.
Biol. 284, 1661–1670.
The folding and unfolding kinetics of the N-terminal domains
of the ribsomal protein L9 have been measured at
temperatures between 7 and 85°C and between 0 and 6 M
guanidine deuterium chloride. Stopped-flow fluorescence was
used to measure rates below 55°C and NMR line-shape
analysis was used above 55°C. The amplitudes and rate
profiles of the stopped-flow fluorescence experiments are
consistent with a two-state folding mechanism, and plots of
ln(k) versus guanidine deuterium chloride concentration show
the classic v-shape indicative of two-state folding .
18 December 1998, Journal of Molecular Biology
 Crystal structure of the Ebola virus membrane fusion subunit, GP2, from
the envelope glycoprotein ectodomain. Winfried Weissenhorn, Andrea Carfi,
kon-Ho Lee, John J Skehel and Don C Wiley (1998). Mol. Cell 2, 605–616.
The authors have determined the crystal structure of GP2 from
the Ebola virus membrane fusion glycoprotein. The molecule
contains a central triple-stranded coiled coil followed by a
disulfide-bonded loop homologous to an immunosuppressive
sequence in retroviral glycoproteins, which reverses the chain
direction and connects to an α helix packed antipararell to the
core helices. The structure suggests that fusion peptides near
the N-termini form disulfide-bonded loops at one end of the
molecule and that the C–terminal membrane anchors are at
the same end. In this conformation, GP2 could both bridge
two membranes and facilitate their apposition to initiate
membrane fusion.
16 November 1998, Molecular Cell
 Structure of the haemagglutinin-esterase-fusion glycoprotein of influenza
C virus. Peter B Rosenthal, Xiaodong Zhang, Frank Formanowski, Wolfgang Fitz,
Chi-Huey Wong, Herbert Meier-Ewert, John J Skehel and Don C Wiley (1998).
Nature 396, 92–96.
Haemagglutinin-esterase-fusion (HEF) protein of influenza C
virus has three functions: to recognize the receptor on the cell
surface, to mediate viral fusion with the cell membrane, and to
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destroy the receptor. This paper describes the crystal
structure of the HEF envelope glycoprotein of influenza C
virus. The receptor-binding site and the receptor-destroying
enzyme (9-O-acetylesterase) sites were identified by using
receptor analogues. The receptor domain is inserted into a
surface loop of the esterase domain and the esterase domain is
inserted into a surface loop of the stem, which is similar to
that of influenza A haemagglutinin.
5 November 1998, Nature
 Crystal structure of a bacterial signal peptidase in complex with a β-
lactam inhibitor. Mark Paetzel, Ross E Dalbey and Natalie CJ Strynadka (1998).
Nature 396, 186–190.
The signal peptidase (SPase) from Escherichia coli is a
membrane-bound endopeptidase with two amino-terminal
transmembrane segments and a carboxy-terminal catalytic
region which resides in the periplasmic space. The crystal
structure of a catalytically active soluble fragment of SPase in a
complex with a β-lactam inhibitor explains the specificity
requirement at the signal-peptide cleavage site, and reveals a
large exposed hydrophobic surface which could be a site for an
intimate association with the membrane.
12 November 1998, Nature
 Three-dimensional structure of the plant photosystem II reaction centre
at 8 Å resolution. Kyong-Hi Rhee, Edward P Morris, James Barber, and Werner
Kühlbrandt (1998). Nature 396, 283–286.
Photosystem II uses solar energy to catalyse the breakdown
of water to reducing equivalents and molecular oxygen. The
structure of a photosystem II subcomplex, determined by
electron crystallography, contains 23 transmembrane α-
helices, of which 16 have been assigned to the D1, D2 and
CP47 proteins. The arrangement of these helices is
remarkably similar to that in the reaction centres of purple
bacteria and of plant photosystem I. The map suggests that
redox cofactors in the D1–D2 complex are also located in
analogous positions.
19 November 1998, Nature
 Structure of α-lytic protease complexed with its pro region. Nicholas K
Sauter, Ted Mau, Stephen D Rader and David A Agard (1998). Nat. Struct. Biol. 5,
945–950.
The extracellular bacterial protease α-lytic protease (αLP) is
synthesized as a pro-enzyme where its pro region (Pro) acts as a
foldase to stabilize the transition state for the folding reaction.
The authors report the crystal structures of Pro and of the non-
covalent inhibitory complex between Pro and native αLP. The
C-shaped Pro surrounds the C-terminal β-barrel domain of the
folded protease, forming a large complementary interface.
Regions of extensive hydration in the interface explain how
Pro binds tightly to the native state, yet even more tightly to
the folding transition state.
November 1998, Nature Structural Biology
 A novel DNA-binding motif shares structural homology to DNA replication
and repair nucleases and polymerases. Yate-Ching Yuan, Robert H Whitson,
Qin Liu, Keiichi Itakura and Yuan Chen (1998). Nat. Struct. Biol. 5, 959–964.
The three-dimensional structure of one of a novel class of
DNA-binding domains, Mrf-2, has been solved using NMR
methods. This structure is significantly different from known
DNA-binding domain structures. This new DNA-binding
motif shares structural homology with T4 RNase H, E. coli
endonuclease III and Bacillus subtilis DNA polymerase I. The
mechanism of DNA recognition by this motif has been
suggested based on conserved residues, surface electrostatic
potentials and chemical shift changes.
November 1998, Nature Structural Biology
 Solution structure of a protein inhibitor of neuronal nitric oxide synthase.
Hidehito Tochio, Shinya Ohki, Qiang Zhang, Ming Li and Mingjie Zhang (1998). Nat.
Struct. Biol. 5, 965–969.
The structure of the neuronal nitric oxide synthase inhibitory
protein, PIN (protein inhibitor of nNOS), has been
determined by NMR spectroscopy. Two N-terminal
antiparallel α-helices pack against a four-stranded antiparallel
β-sheet in the C-terminal region of the protein, forming a two-
layer α/β plait. The three dimensional structure of PIN
resembles the fold of the B-chain of aspartylglucosaminidase.
PIN has a large solvent-exposed hydrophobic surface that
contains a cavity and is rimmed with positive charges that may
serve as the primary target-binding region.
November 1998, Nature Structural Biology
 An antagonist peptide–EPO receptor complex suggests that receptor
dimerization is not sufficient for activation. Oded Livnah, Dana L Johnson,
Enrico A Stura, Francis X Farrell, Francis P Barbone, Yun You, Kathleen D Liu,
Mark A Goldsmith, Wen He, Christopher D Krause, Sidney Pestka, Linda K Jolliffe
and Ian A Wilson (1998). Nat. Struct. Biol. 5, 993–1004.
Dimerization of the erythropoietin (EPO) receptor (EPOR),
in the presence of either natural (EPO) or synthetic 
(EPO-mimetic peptides, EMPs) ligands is the principal
extracellular event that leads to receptor activation. The
crystal structure of the extracellular domain of EPOR bound
to an inactive (antagonist) peptide has unexpectedly revealed
that dimerization still occurs, but the orientation between
receptor molecules is altered relative to active (agonist)
peptide complexes.
November 1998, Nature Structural Biology
 Heme packing motifs revealed by the crystal structure of the tetra-heme
cytochrome c554 from Nitrosomonas europaea. Tina M Iverson, David M
Arciero, Barbara T Hsu, Michael SP Logan, Alan B Hooper and Douglas C Rees
(1998). Nat. Struct. Biol. 5, 1005–1012.
Cytochrome c554 (cyt c554), a tetra-heme cytochrome from
Nitrosomonas europaea, is an essential component in the
biological nitrification pathway. In N. europaea, ammonia is
converted to hydroxylamine, which is then oxidized to nitrite
by hydroxylamine oxidoreductase (HAO). The crystal
structure of cyt c554 shows a predominantly α-helical protein
with four covalently attached hemes. The four hemes are
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arranged in two pairs such that the planes of the porphyrin
rings are almost parallel and overlapping at the edge. Striking
structural similarities are evident between the tetra-heme core
of cyt c554 and hemes 3–6 of HAO, which suggests an
evolutionary relationship between them.
November 1998, Nature Structural Biology
 Structure of the outer membrane protein A transmembrane domain. Alex
Pautsch and Georg E Schulz (1998). Nat. Struct. Biol. 5, 1013–1017.
The authors have determined the crystal structure of the outer
membrane protein A (OmpA) transmembrane domain
consisting of residues 1–171. It consists of a regular, extended
eight-stranded β-barrel and appears to be constructed like an
inverse micelle with large water-filled cavities, but does not
form a pore. The structure constitutes a β-barrel membrane
anchor that appears to be the outer membrane equivalent of
the single-chain α-helix anchor of the inner membrane. 
November 1998, Nature Structural Biology
 Characterization of a folding intermediate from HIV-1 ribonuclease H.
Gunther Kern, Tracy Handel, Susan Marqusee (1998). Protein Sci. 7, 2164–2174.
The RNase H domain from HIV-1 (HIV RNase H) encodes an
essential retroviral activity. Refolding of the isolated HIV
RNase H domain shows a kinetic intermediate detectable by
stopped-flow far UV circular dichroism and pulse-labeling H/D
exchange. In this intermediate, strands 1, 4, and 5 as well as
helices A and D appear to be structured. Compared to its
homolog from Escherichia coli, the rate limiting step in refolding
of HIV RNase H appears closer to the native state. The
authors have modeled this kinetic intermediate using a 
C-terminal deletion fragment lacking helix E. Like the kinetic
intermediate, this variant folds rapidly and shows a decrease in
stability. The authors propose that inhibition of the docking of
helix E to this folding intermediate may present a novel
strategy for anti HIV-1 therapy. 
October 1998, Protein Science
 Stabilizing the subtilisin BPN′ pro-domain by phage display selection:
how restrictive is the amino acid code for maximum protein stability?
Bioa Ruan, Joel Hoskins, Lan Wang, Philip N Bryan (1998). Protein Sci. 7,
2345–2353.
The authors have devised a procedure using monovalent
phage display to select for stable mutants in the pro-domain of
the serine protease, subtilisin BPN′. These experiments use
combinatorial mutagenesis to select for stabilizing amino acid
combinations at a particular structural locus and determine how
many combinations are close to the maximum protein stability.
Previous studies using combinatorial genetics have shown that
many different combinations of amino acids can be
accommodated in a selected locus without destroying function.
The present results indicate that the number of sequence
combinations at a structural locus that are close to the
maximum stability is small. Some implications of these results
on the amount of sequence information needed to specify a
unique tertiary fold are discussed.
November 1998, Protein Science
 Structure of human methionine aminopeptidase-2 complexed with
fumagillin. Shenping Liu, Joanne Widom, Christopher W Kemp, Craig M Crews
and Jon Clardy (1998). Science 282, 1324–1327.
The fungal metabolite fumagillin suppresses the formation of
new blood vessels, and a fumagillin analog is currently in
clinical trials as an anticancer agent. The molecular target of
fumagillin is methionine aminopeptidase-2 (MetAP-2). Crystal
structures of free and inhibited human MetAP-2 show a
covalent bond formed between a reactive epoxide of
fumagillin and histidine-231 in the active site of MetAP-2.
Extensive hydrophobic and water-mediated polar interactions
with other parts of fumagillin provide additional affinity.
13 November 1998, Science
 A structural explanation for the recognition of tyrosine-based endocytotic
signals. David J Owen and Philip R Evans (1998). Science 282, 1327–1332.
Many cell surface proteins are marked for endocytosis by a
cytoplasmic sequence motif, tyrosine-X-X-(hydrophobic
residue), that is recognized by the µ2 subunit of AP2 adaptors.
Crystal structures of the internalization signal binding domain
of µ2 complexed with the internalization signal peptides of
epidermal growth factor receptor and the trans-Golgi network
protein TGN38 have been determined. The signal peptides
adopted an extended conformation rather than the expected
tight turn. Specificity is conferred by hydrophobic pockets that
bind the tyrosine and leucine in the peptide. In the crystal, the
protein forms dimers that could increase the strength and
specificity of binding to dimeric receptors.
13 November 1998, Science
 Structure of a covalently trapped catalytic complex of HIV-1 reverse
transcriptase: implications for drug resistance. Huifang Huang, Rajiv Chopra,
Gregory L Verdine and Stephen C Harrison (1998). Science 282, 1669–1675.
A combinatorial disulfide cross-linking strategy was used to
prepare a stalled complex of human immunodeficiency virus-
type 1 (HIV-1) reverse transcriptase with a DNA
template:primer and a deoxynucleoside triphosphate (dNTP),
and the crystal structure of the complex was determined. The
presence of a dideoxynucleotide at the 3′-primer terminus
allows capture of a state in which the substrates are poised for
attack on the dNTP. Conformational changes that accompany
formation of the catalytic complex produce distinct clusters of
the residues that are altered in viruses resistant to nucleoside
analog drugs. The positioning of these residues in the
neighborhood of the dNTP helps to resolve some long-
standing puzzles about the molecular basis of resistance.
27 November 1998, Science
 The structure of an insect parvovirus (Galleria mellonella densovirus) at
3.7 Å resolution. Alan A Simpson, Paul R Chipman, Timothy S Baker, Peter
Tijssen and Michael G Rossmann (1998). Structure 6, 1355–1367.
The Galleria mellonella densovirus (GmDNV) capsid protein
consists of a core β-barrel motif, similar to that found in many
other viral capsid proteins. The structure most closely
resembles that of the vertebrate parvoviruses, but it has
diverged beyond recognition in many of the long loop regions
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that constitute the surface features and intersubunit contacts.
The N termini of twofold-related subunits have swapped their
positions relative to those of the vertebrate parvoviruses, which
may have the effect of increasing capsid stability in GmDNV.
15 November 1998, Structure
 Glycerol kinase from Escherichia coli and an Ala65→Thr mutant: the
crystal structures reveal conformational changes with implications for
allosteric regulation. Michael D Feese, H Rick Faber, Cory E Bystrom, Donald W
Pettigrew and S James Remington (1998). Structure 6, 1407–1418.
Glycerol kinase (GK) from Escherichia coli is a velocity-
modulated (V system) enzyme that has three allosteric
effectors with independent mechanisms. The crystal structure
contains a 222 symmetric tetramer. The tetramer interface is
significantly different, however, with a relative 22° rotation and
6 Å translation of one functional dimer. These movements
create an orthophosphate binding site. Possible mechanisms of
allosteric regulation are discussed.
15 November 1998, Structure
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